Related Experiment Video
Updated: Jan 6, 2026
28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
33.8K
[Atrial fibrillation therapy: different opinions]
1UOC Pronto soccorso e Medicina d'urgenza, ASL Viterbo.
Recenti Progressi in Medicina
|October 9, 2019
Summary
Atrial fibrillation management is evolving with new anticoagulant drugs. Guidelines recommend them for non-valvular cases, but some bulletins urge caution, highlighting the need for evidence-based decisions.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Atrial fibrillation (AF) is a prevalent cardiac arrhythmia with increasing incidence.
- Therapeutic strategies for AF have expanded with novel anticoagulant medications.
Discussion:
- Divergent expert opinions exist regarding the use of new anticoagulant drugs in non-valvular atrial fibrillation.
- Accredited guidelines (e.g., published in Chest) advocate for new anticoagulants, contrasting with more conservative stances in independent drug information bulletins.
Key Insights:
- The scientific community is divided on the optimal use of emerging anticoagulant therapies for atrial fibrillation.
- Evidence-based decision-making is crucial for clinicians managing this common arrhythmia.
Outlook:
- Government institutions should monitor clinical choices and ensure access to robust evidence for healthcare providers.
- Continued evaluation of new anticoagulant efficacy and safety is essential for refining treatment protocols.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
251
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
251
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
406
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
406
01:25Dysrhythmias VI: Management of Dysrhythmias
368
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
368
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.0K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.0K
01:22Heart Failure VI: Adjunct Therapies
223
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
223
01:29Disturbances in Heart Rhythm
2.4K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
2.4K